Related Experiment Video
Updated: Aug 6, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Reversible pre-capillary pulmonary hypertension due to long-standing arteriovenous fistula
Laura Saldivar1, Emily Garber2, Khaled Boubes3
1Department of Pulmonary, Critical Care & Sleep Medicine at the Ohio State University Wexner Medical Center, Columbus, OH, USA.
Abstract:
Chronic kidney disease predisposes patients to the development of pulmonary hypertension (PH) via multiple potential mechanisms. AV fistulas have been found to be superior to AV grafts in terms of maintaining patency, however unlike grafts fistulas can expand significantly over time which predisposes patients to high output heart failure and subsequent PH. This report demonstrates a case of newly diagnosed pre-capillary PH in a young patient presenting with dyspnea. The patient had an AV fistula placed 18 years prior to presentation for CKD and ultimately underwent transplantation. Pulmonary angiography was negative for PE and echocardiography demonstrated an elevated RVSP of 67 mmHg that was confirmed via right heart catheterization. This case was unique in that the patient's pre-capillary PH was reversed after AV fistula ligation and the patient also experienced improvement in renal graft function (Cr 1.43 to 1.2 mg/dL). AV fistulas can have a significant effect on cardiac function and clinicians should survey patients with AV fistulas for PH via screening echocardiography. Fistulas with outputs greater than 1.5-2 L/min should be considered for revision or ligation to decrease the risk of development of PH.
More Related Videos
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
Related Concept Videos
Portal Hypertension
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Edema II: Pathophysiology
Hemodialysis I: Introduction
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Cardiac Catheterization II: Right Heart Catheterization